公司自2017年开始专注于细胞药物研发,近十年时间,已经积累丰富行业经验并已取得多项单适应症研究成果。目前在山东、上海研究所均稳定运营,2025年进入北京亦庄,依托亦庄新药研发基地开展细胞药物研发,志在打通干细胞临床应用的*后一公里。
公司核心产品包含:干细胞制剂、免疫细胞制剂、外泌体产品、化妆品等细胞及相关衍生品。
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows